Mimedx (MDXG) Tax Rate Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,186.00 |
| Dec 31, 2025 | 3,002.00 |
| Sep 30, 2025 | 2,733.00 |
| Jun 30, 2025 | 2,663.00 |
| Mar 31, 2025 | 1,906.00 |
| Dec 31, 2024 | 15,256.00 |
| Sep 30, 2024 | 4,578.00 |
| Jun 30, 2024 | 2,382.00 |
| Mar 31, 2024 | 2,128.00 |
| Dec 31, 2023 | -27,443.00 |
| Sep 30, 2023 | 646.00 |
| Jun 30, 2023 | -49.00 |
| Mar 31, 2023 | -7,280.00 |
| Dec 31, 2022 | 332.00 |
| Sep 30, 2022 | 193.00 |
| Jun 30, 2022 | -33.00 |
| Mar 31, 2022 | -29.00 |
| Dec 31, 2021 | 19,640.00 |
| Sep 30, 2021 | -15,248.00 |
| Jun 30, 2021 | 101.00 |
| Mar 31, 2021 | 4,991.00 |
| Dec 31, 2020 | -4,464.00 |
| Sep 30, 2020 | 363.00 |
| Jun 30, 2020 | -1,419.00 |
| Mar 31, 2020 | 6,547.00 |
| Dec 31, 2019 | -3,470.00 |
| Sep 30, 2019 | -3,061.00 |
| Jun 30, 2019 | -4,300.00 |
| Mar 31, 2019 | -1,548.00 |
| Dec 31, 2018 | -24,095.00 |
| Sep 30, 2018 | 13,536.00 |
| Jun 30, 2018 | -467.00 |
| Mar 31, 2018 | -5,405.00 |
| Dec 31, 2017 | 3,299.00 |
| Sep 30, 2017 | -442.00 |
| Jun 30, 2017 | 1,137.00 |
| Mar 31, 2017 | 573.00 |
| Dec 31, 2016 | 3,189.00 |
| Sep 30, 2016 | 4,599.00 |
| Mar 31, 2016 | 1,837.00 |